Beam nasdaq
WebApr 10, 2024 · Beam Therapeutics Price Performance. NASDAQ:BEAM opened at $29.74 on Monday. The firm has a market capitalization of $2.15 billion, a P/E ratio of -7.20 and a beta of 1.63. The business has a 50 ... WebMar 20, 2024 · Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which …
Beam nasdaq
Did you know?
WebApr 10, 2024 · Beam Therapeutics Price Performance. NASDAQ:BEAM opened at $29.74 on Monday. The firm has a market capitalization of $2.15 billion, a P/E ratio of -7.20 and … Web3 hours ago · In December 2024, Beam Therapeutics had US$1.1b in cash, and was debt-free. In the last year, its cash burn was US$26m. So it had a very long cash runway of …
Web2 days ago · The latest price target for Beam Therapeutics ( NASDAQ: BEAM) was reported by Wells Fargo on Wednesday, March 1, 2024. The analyst firm set a price target for … WebBeam Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. BEAM updated stock price target summary.
WebBeam Therapeutics Inc. Common Stock (BEAM) After-Hours Quotes Nasdaq Search for After Hours Quote After-Hours: BEAM Edit my quotes Beam Therapeutics Inc. Common Stock (BEAM) 0 Add to... WebFeb 8, 2024 · Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which includes access to base editing technologies and associated technologies that enhance the scope of base editing.
WebNext quarter’s sales forecast for BEAM is $15.61M with a range of $5.00M to $21.30M. The previous quarter’s sales results were $20.04M. BEAM beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 42.02% of the time in the same period.
WebApr 6, 2024 · About Beam Therapeutics Inc. Beam Therapeutics, Inc. develops and commercializes DNA base editing technologies for the treatment of human disease. Its licensed technology platform, which... free office.com setupWebBEAM Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 266 Institutional Holders 54,243,673 Total Shares Held Back to BEAM Overview Institutional Holdings... farm and fisherman cherry hill dinner menuWebApr 13, 2024 · Beam Therapeutics (NASDAQ:BEAM – Get Rating) last announced its quarterly earnings data on Tuesday, February 28th. The company reported ($0.54) … free office communicator programWebFind real-time BEAM - Beam Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Beam Therapeutics Inc (NASDAQ:BEAM) 29.76. Delayed Data. As of Apr 12 -0.33 ... free office communication softwareWebApr 14, 2024 · The current stock price for Beam Therapeutics Inc. (BEAM) is $32.24. The stock experienced a significant increase during the last trading session, reaching $32.82 after opening at $30.00. It dipped to a low of $29.90 before ultimately closing at $29.75. Top 5 EV Tech Stocks to Buy for 2024 farm and fisherman horsham happy hourWebBEAM THERAPEUTICS INC. 29.74. at close. +0.42 ( +1.43%) after hours • as of Apr 6, 07:51 PM EDT. 29.89. +0.15 ( +0.50%) 1D. 5D. farm and fisherman cherry hill reservationsWebJan 16, 2024 · Beam Therapeutics is a preclinical startup that's developing gene therapies and expects to begin clinical trials in the second half of 2024. Its base-editing technology could be a much more... farm and fisherman horsham